Related references
Note: Only part of the references are listed.Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer
Rafael Molina et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Elevation of serum squamous cell carcinoma antigen 2 in patients with psoriasis: associations with disease severity and response to the treatment
Y. Watanabe et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
The roles of miRNAs as potential biomarkers in lung diseases
Shamila D. Alipoor et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
The diagnostic accuracy of carcinoembryonic antigen to detect colorectal cancer recurrence - A systematic review
Caspar G. Sorensen et al.
INTERNATIONAL JOURNAL OF SURGERY (2016)
Therapeutic effect of anti CEACAM6 monoclonal antibody against lung adenocarcinoma by enhancing anoikis sensitivity
Kwon Pyo Hong et al.
BIOMATERIALS (2015)
Role of a serum-based biomarker panel in the early diagnosis of lung cancer for a cohort of high-risk patients
Da-Wei Yang et al.
CANCER (2015)
Optimal cut-off values for CYFRA 21-1 expression in NSCLC patients depend on the presence of benign pulmonary diseases
Rui Huan Xu et al.
CLINICA CHIMICA ACTA (2015)
Practice Guideline for the Surveillance of Patients After Curative Treatment of Colon and Rectal Cancer
Scott R. Steele et al.
DISEASES OF THE COLON & RECTUM (2015)
Superior Immunologic and Therapeutic Efficacy of a Xenogeneic Genetic Cancer Vaccine Targeting Carcinoembryonic Human Antigen
Luigi Aurisicchio et al.
HUMAN GENE THERAPY (2015)
Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer
Youtao Xu et al.
SCIENTIFIC REPORTS (2015)
MicroRNA-Dependent Regulation of Transcription in Non-Small Cell Lung Cancer
Sonia Molina-Pinelo et al.
PLOS ONE (2014)
The Prognostic Value of Serum Neuron-Specific Enolase in Traumatic Brain Injury: Systematic Review and Meta-Analysis
Feng Cheng et al.
PLOS ONE (2014)
Prognostic significance of preoperative serum carcinoembryonic antigen in non-small cell lung cancer: a meta-analysis
Xiao-Bin Wang et al.
TUMOR BIOLOGY (2014)
Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis
Zhe Huang et al.
TUMOR BIOLOGY (2014)
Prognostic impact of serum CYFRA 21-1 in patients with advanced lung adenocarcinoma: a retrospective study
Akira Ono et al.
BMC CANCER (2013)
Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis
Nicole Beauchemin et al.
CANCER AND METASTASIS REVIEWS (2013)
Prognostic Value of Tumor Markers, NSE, CA125 and SCC, in Operable NSCLC Patients
Dangfan Yu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
New Pathologic Classification of Lung Cancer: Relevance for Clinical Practice and Clinical Trials
William D. Travis et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Cytokeratin 19 Fragment Predicts the Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor in Non-Small-Cell Lung Cancer Harboring EGFR Mutation
Kosuke Tanaka et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Preoperative serum CYFRA 21-1 level as a prognostic factor in surgically treated adenocarcinoma of lung
Seong Yong Park et al.
LUNG CANCER (2013)
Sialyl Lewis X as a predictor of skip N2 metastasis in clinical stage IA non-small cell lung cancer
Hiroaki Komatsu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
Maximum SUV on positron emission tomography and serum CEA level as prognostic factors after curative resection for non-small cell lung cancer
Masaki Tomita et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2012)
CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non-Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304
Martin J. Edelman et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer
M. Grunnet et al.
LUNG CANCER (2012)
Biomarkers in the Lung Cancer Diagnosis: A Clinical Perspective
X. Li et al.
NEOPLASMA (2012)
A prognostic score based on clinical factors and biomarkers for advanced non-small cell lung cancer
Jaume Trape et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2012)
The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited
Shaohua Ma et al.
CANCER BIOMARKERS (2011)
Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non-Small-Cell Lung Cancer (NSCLC)
Susana Cedres et al.
CLINICAL LUNG CANCER (2011)
Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancer
Luigi De Petris et al.
EUROPEAN JOURNAL OF CANCER (2011)
Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer
Takeshi Hanagiri et al.
LUNG CANCER (2011)
Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?
Takashi Hirose et al.
LUNG CANCER (2011)
Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers
Pierre-Jean Lamy et al.
BREAST CANCER RESEARCH (2011)
The Value of Tumor Markers in Evaluating Chemotherapy Response and Prognosis in Chinese Patients with Advanced Non-Small Cell Lung Cancer
Bo Jin et al.
CHEMOTHERAPY (2010)
A Combination of Serum Markers for the Early Detection of Colorectal Cancer
Norbert Wild et al.
CLINICAL CANCER RESEARCH (2010)
Elevated serum levels of TPS and CYFRA 21-1 predict poor prognosis in advanced non-small-cell lung cancer patients treated with gefitinib
Fengsheng Chen et al.
MEDICAL ONCOLOGY (2010)
Intralobar Pulmonary Sequestration Associated With Marked Elevation of Serum Carbohydrate Antigen 19-9
Satoshi Ambiru et al.
ANNALS OF THORACIC SURGERY (2009)
Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis
Oscar Arrieta et al.
BMC CANCER (2009)
Toward unraveling the complexity of simple epithelial keratins in human disease
M. Bishr Omary et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Comparison of Serum CA 19.9, CA 125 and CEA Levels with Severity of Chronic Obstructive Pulmonary Disease
I. Bulut et al.
MEDICAL PRINCIPLES AND PRACTICE (2009)
Serum carcinoembryonic antigen level in non-small-cell lung cancer patients with preoperative normal serum level
Masaki Tomita et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2009)
Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients
W. Jacot et al.
ANNALS OF ONCOLOGY (2008)
Nucleosomes, ProGRP NSE, CYFRA 21-1, and CEA in Monitoring First-Line Chemotherapy of Small Cell Lung Cancer
Stefan Holdenrieder et al.
CLINICAL CANCER RESEARCH (2008)
Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors
Nobuhisa Ishikawa et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: Clinicopathologic characteristics and prognosis
Haruhisa Matsuguma et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2008)
Circulating Serum Vascular Endothelial Growth Factor is Not a Prognostic Factor of Non-small Cell Lung Cancer
Mohammad Chakra et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Preoperative CYFRA 21-1 and CEA as Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer
Florian Blankenburg et al.
TUMOR BIOLOGY (2008)
Progastrin-releasing peptide: Stability in plasma/serum and upper reference limit
Marianne S. Nordlund et al.
TUMOR BIOLOGY (2008)
Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival
B. Nisman et al.
BRITISH JOURNAL OF CANCER (2008)
Preoperative CYFRA 21-1 levels as a prognostic factor in c-stage I non-small cell lung cancer
Hisashi Suzuki et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2007)
Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer
Katsunari Matsuoka et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2007)
Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or less
Naruyuki Kobayashi et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung
Ryuta Fukai et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2007)
Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer
Wen-Hu Hsu et al.
ANNALS OF THORACIC SURGERY (2007)
Stage IA non-small cell lung cancer: Vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy
Tomoshi Tsuchiya et al.
LUNG CANCER (2007)
Clinical value of serum cytokeratin 19 fragment and sialyl-Lewis x in non-small cell lung cancer
Shinjiro Mizuguchi et al.
ANNALS OF THORACIC SURGERY (2007)
The prognostic significance of circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer
B Nisman et al.
TUMOR BIOLOGY (2006)
Synthesis, expression and biological activity of the prohormone for gastrin releasing peptide (ProGRP)
C Dumesny et al.
ENDOCRINOLOGY (2006)
CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy
F Barlési et al.
BRITISH JOURNAL OF CANCER (2005)
Galectin-1 receptors in different cell types
MT Elola et al.
JOURNAL OF BIOMEDICAL SCIENCE (2005)
Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer
F Barlési et al.
RESPIRATORY MEDICINE (2004)
Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma
M Okada et al.
ANNALS OF THORACIC SURGERY (2004)
Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor
A Iwasaki et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2004)
Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: Analysis of 1,000 consecutive resections for clinical stage I disease
M Okada et al.
ANNALS OF THORACIC SURGERY (2004)
The discovery, biology, and drug development of sialyl Lea and sialyl Lex
JL Magnani
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
Pro-gastrin-releasing peptide in patients with benign and malignant diseases
R Molina et al.
TUMOR BIOLOGY (2004)
Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death lung cancer in resectable non-small lung cancer
M Pollán et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC)
D Ferrigno et al.
LUNG CANCER (2003)
Clinical equivalence of two cytokeratin markers in non-small cell lung cancer - A study of tissue polypeptide antigen and cytokeratin 19 fragments
G Buccheri et al.
CHEST (2003)
Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension
M Okada et al.
CANCER (2003)
Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer
T Uenishi et al.
BRITISH JOURNAL OF CANCER (2003)
Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer
JL Pujol et al.
LUNG CANCER (2003)
Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis - Comparison with the main clinical and pathological prognostic factors
R Molina et al.
TUMOR BIOLOGY (2003)
Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer
N Sawabata et al.
ANNALS OF THORACIC SURGERY (2002)
Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer
N Reinmuth et al.
LUNG CANCER (2002)
Carcinoembryonic antigen as a target for therapeutic anticancer vaccines: A review
NL Berinstein
JOURNAL OF CLINICAL ONCOLOGY (2002)
'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments
PA Coulombe et al.
CURRENT OPINION IN CELL BIOLOGY (2002)
Prognostic value of serum tumor markers in patients with lung cancer
KD Hatzakis et al.
RESPIRATION (2002)
Lung tumor markers of cytokeratin origin: an overview
G Buccheri et al.
LUNG CANCER (2001)
Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC)
T Shibayama et al.
LUNG CANCER (2001)
Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients
JL Pujol et al.
LUNG CANCER (2001)
Prognostic factors in advanced non-small cell lung cancer: Elevated serum levels of neuron specific enolase indicate poor prognosis
T Maeda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
